JPWO2022225852A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022225852A5 JPWO2022225852A5 JP2023563942A JP2023563942A JPWO2022225852A5 JP WO2022225852 A5 JPWO2022225852 A5 JP WO2022225852A5 JP 2023563942 A JP2023563942 A JP 2023563942A JP 2023563942 A JP2023563942 A JP 2023563942A JP WO2022225852 A5 JPWO2022225852 A5 JP WO2022225852A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- tcr
- cells
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163176477P | 2021-04-19 | 2021-04-19 | |
| US63/176,477 | 2021-04-19 | ||
| PCT/US2022/025223 WO2022225852A1 (en) | 2021-04-19 | 2022-04-18 | Methods and compositions comprising mhc class i peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024517630A JP2024517630A (ja) | 2024-04-23 |
| JPWO2022225852A5 true JPWO2022225852A5 (https=) | 2025-08-19 |
| JP2024517630A5 JP2024517630A5 (https=) | 2025-08-19 |
Family
ID=83722630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563942A Pending JP2024517630A (ja) | 2021-04-19 | 2022-04-18 | Ｍｈｃクラスｉペプチドを含む方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240207406A1 (https=) |
| EP (1) | EP4326306A4 (https=) |
| JP (1) | JP2024517630A (https=) |
| KR (1) | KR20230172572A (https=) |
| CN (1) | CN117425665A (https=) |
| AU (1) | AU2022260281A1 (https=) |
| BR (1) | BR112023021806A2 (https=) |
| CA (1) | CA3217185A1 (https=) |
| IL (1) | IL307802A (https=) |
| MX (1) | MX2023012367A (https=) |
| WO (1) | WO2022225852A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10130693B2 (en) * | 2015-08-28 | 2018-11-20 | Immatics Biotechnologies Gmbh | Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
| GB201515321D0 (en) * | 2015-08-28 | 2015-10-14 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
-
2022
- 2022-04-18 CN CN202280035973.1A patent/CN117425665A/zh active Pending
- 2022-04-18 BR BR112023021806A patent/BR112023021806A2/pt unknown
- 2022-04-18 WO PCT/US2022/025223 patent/WO2022225852A1/en not_active Ceased
- 2022-04-18 US US18/556,054 patent/US20240207406A1/en active Pending
- 2022-04-18 EP EP22792271.3A patent/EP4326306A4/en not_active Withdrawn
- 2022-04-18 IL IL307802A patent/IL307802A/en unknown
- 2022-04-18 JP JP2023563942A patent/JP2024517630A/ja active Pending
- 2022-04-18 AU AU2022260281A patent/AU2022260281A1/en not_active Abandoned
- 2022-04-18 KR KR1020237039797A patent/KR20230172572A/ko active Pending
- 2022-04-18 MX MX2023012367A patent/MX2023012367A/es unknown
- 2022-04-18 CA CA3217185A patent/CA3217185A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250188145A1 (en) | Tcr and peptides | |
| KR102618231B1 (ko) | 변형된 만능성 줄기 세포, 및 제조 및 사용 방법 | |
| CN106074601B (zh) | 用于细胞免疫治疗的方法和组合物 | |
| BR112021003305A2 (pt) | métodos para produzir células que expressam receptor de antígeno quimérico | |
| US12076343B2 (en) | Engineered safety in cell therapy | |
| US20220096546A1 (en) | Modified Cell Expansion and Uses Thereof | |
| JP2022513148A (ja) | Ｔ細胞の改変 | |
| US20210100841A1 (en) | Presenting cell and use thereof in cell therapy | |
| US20210060069A1 (en) | Coupled redirected cells and uses thereof | |
| CN108137670A (zh) | Ny-eso-1特异性tcr及其使用方法 | |
| US20210137983A1 (en) | Nk cell expansion and uses thereof | |
| US20210024890A1 (en) | Modulating t cell function and response | |
| US20210379149A1 (en) | Increasing or Maintaining T-Cell Subpopulations in Adoptive T-Cell Therapy | |
| JP2017522859A (ja) | グリピカン３に特異的なｔ細胞受容体、及び肝細胞癌の免疫療法のためのその使用 | |
| US20230201258A1 (en) | Polyspecific Binding Molecules and their use in Cell Therapy | |
| CN111826353B (zh) | 调节t细胞功能和反应的方法 | |
| CN117165532A (zh) | 具有增强的迁移能力的修饰的细胞 | |
| US20260035425A1 (en) | Membrane-anchored cytokines, engineered immune cells, and uses thereof | |
| EP3892720A1 (en) | Presenting cell and use thereof in cell therapy | |
| JPWO2022225852A5 (https=) | ||
| JPWO2021163562A5 (https=) | ||
| JPWO2023004289A5 (https=) | ||
| JPWO2022216856A5 (https=) | ||
| CA3125646A1 (en) | Modified cell expansion and uses thereof | |
| US20240075061A1 (en) | Cell therapy activating lymphocyte in tme |